Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW Files Criminal Complaint against Novartis over Diovan Ads
January 9, 2014
-
BUSINESS Former Pfizer EPBU Head Matsumori Joins SBI Biotech as President
January 8, 2014
-
REGULATORY MHLW to File Criminal Complaint against Novartis Jan. 8
January 8, 2014
-
REGULATORY MHLW Economic Affairs Official Says Shakeout in Generic Sphere “Inevitable”
January 7, 2014
-
BUSINESS New Price Cut Rule for Long-Listed Products Blow to Drug Makers
January 6, 2014
-
ORGANIZATION New Price Cut for Long-Listed Products “Harsh,” Needs Follow-Up Review: FPMAJ Chair Naito
January 1, 2014
-
BUSINESS Takeda to End Development of TAK-875 Due to Liver Safety Concerns
December 27, 2013
-
BUSINESS Nissan Chemical Sues Seven Generic Companies over Livalo Patents
December 27, 2013
-
REGULATORY Chuikyo Approves Outline for NHI Price Reform Including New Rule for Long-Listed Drugs; Trial of Premium for New Drug Development to Continue
December 26, 2013
-
REGULATORY FY2014 Budget: 95.4 Billion Yen for Japan NIH, Development of Novel Drugs
December 25, 2013
-
REGULATORY FY2014 NHI Price Revision Down 5.7% Excluding Tax Adjustments
December 24, 2013
-
BUSINESS Bristol to Sell Global Diabetes Biz to AstraZeneca; Deal Covers SGLT-2 Asset Transfer
December 20, 2013
-
REGULATORY Off-Patent Drugs to Get Continuous Price Cuts Until 60% Generic Share Reached
December 19, 2013
-
ACADEMIA Chiba University Finds No Proof of Manipulation in Diovan Study
December 18, 2013
-
BUSINESS Hyperlipidemia Treatment PCSK9 Inhibitors May Be Launched in Japan in 2016
December 17, 2013
-
REGULATORY Diovan Panel to Reopen Discussions on Dec. 25, Hear from 3 Universities
December 17, 2013
-
ACADEMIA Nagoya University Denies Diovan Clinical Data Manipulated
December 16, 2013
-
REGULATORY No Diovan, Livalo AGs for December Generic NHI Listing
December 13, 2013
-
BUSINESS AstraZeneca Japan Sees Annual Growth of Around 8%, Eyes Addition of 160 Reps
December 13, 2013
-
REGULATORY PFSB Begins Discussions Toward Lifting Ban on Subcontracting of Safety Management Tasks
December 12, 2013
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…